88
Views
56
CrossRef citations to date
0
Altmetric
Original Article

Hyperplastic Lesions of the Gingiva and Alveolar Mucosa

A Study of 175 Cases

&
Pages 75-86 | Received 10 Oct 1981, Published online: 02 Jul 2009
 

Abstract

175 ‘epulides’ were studied clinically and histologically. The lesions were histologically reclassified into three groups: granulomatous, fibromatous and giant cell lesions. The granulomatous group was four times and the giant cell group 1.5 times more frequent in females. It is suggested that the expression epulis should be abandoned as a microscopic designation for lesions in the oral mucosa, as it is only a non-specific topographico-clinical concept comprising histogenetically and histomorphologically differing lesions and therefore does not represent a uniform group. The suggested new terms for the three types of hyperplastic lesions are oral mucosal granulomatous hyperplasias (including such diagnostic terms as granulomatous gingivitis, gingivitis of pregnancy, granuloma gravidarium, pyogenic granuloma, epulis angiomatosa and epulis telangiectaticum), oral mucosal fibrous hyperplasias (including such diagnostic terms as fibrous epulis, epulis fissuratum, fibroepithelial lesions, denture injury tumor and peripheral odontogenic fibroma) and oral mucosal giant cell hyperplasia (including such diagnostic terms as peripheral giant cell granuloma and giant cell epulis).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.